Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Trends in Cancer Research   Volumes    Volume 3 
Current treatment of advanced hepatocellular carcinoma
Katsuharu Hirano, Yukihiro Shimizu
Pages: 53 - 61
Number of pages: 9
Trends in Cancer Research
Volume 3 

Copyright © 2007 Research Trends. All rights reserved

Hepatocellular carcinoma (HCC) is a frequent malignancy worldwide. Although resection or local therapy with radiofrequency ablation could improve survival, a significant portion of patients is unable to undergo those curative therapies due to multiple tumor occurrence or vascular involvement. Those patients are often treated with intraarterial infusion of chemotherapeutic agents. Although there is no standard chemotherapy regimen, intraarterial infusion of CDDP, alone or in combination with 5-FU, or intraarterial infusion of 5-FU and subcutaneous injection of IFN, have been reported to be effective for advanced HCC. Moreover, attempts at radiotherapy or immuno-therapy have achieved promising results. Despite those advances, overall survival of patients with HCC has not been improved over the past three decades. Future development of molecular targeting therapies or new chemotherapeutic agents and overcoming drug resistance may enhance survival.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms